Furthermore, our findings suggest that activation of endothelial STAT3 may have important implications in the therapeutic approach to AKI; however, it is also evident that timing, degree of activation, and cell-specific targeting are additional hurdles that need to be clarified in future studies [29, 53–58]. The gene discussed is STAT3; the disease is acute kidney injury.